Trials / Completed
CompletedNCT00911703
Determining When Patients Hospitalized With Acute Heart Failure Can Be Safely Sent Home (The DECIDE Study)
Treatment Endpoints in Acute Decompensated Heart Failure
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 835 (actual)
- Sponsor
- Vanderbilt University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if certain findings (blood tests, symptom improvement, etc.) after acute heart failure treatment can identify a group of patients who are safe for early hospital discharge.
Detailed description
A fundamental question faced by physicians treating acute decompensated heart failure (ADHF) is "When has treatment worked sufficiently for safe discharge, and who requires further treatment?" Patients with ADHF have a high incidence of morbidity and mortality. Current guidelines for emergency department (ED) and hospital disposition of patients with ADHF are based on limited empirical evidence. This creates clinical uncertainty regarding disposition leads to prolonged hospitalizations, higher costs and increased resource consumption. The specific aim of the study is to develop a prediction rule from readily available clinical data to help physicians identify ADHF patients eligible for safe and early discharge from the ED and hospital after treatment is initiated.
Conditions
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2014-07-01
- Completion
- 2015-10-01
- First posted
- 2009-06-02
- Last updated
- 2016-04-29
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00911703. Inclusion in this directory is not an endorsement.